Projects
Filter By
Filter by:
24Haymarket Limited
24Haymarket invests aligned private capital to accelerate the commercial success of businesses at the early stages of commercial adoption.
More Information
ACT Ventures
ACT Venture Partners (ACT) is an experienced early-stage VC investor with a proven track record of backing deep tech ventures in Europe and the UK.
More Information
ADA Ventures
Ada Ventures is the inclusive venture firm which finds and funds extraordinary talent building breakthrough ideas for the hardest problems we face.
More Information
Albion Capital Group LLP
AlbionVC supports visionary founders with long-term capital and scale-up expertise.
More Information
Amadeus Capital Partners
Amadeus was founded in 1997 by Anne Glover (formerly at APAX Partners and Bain & Co) and Hermann Hauser (co-founder of Acorn Computers which spun out ARM, the microprocessor giant).
More Information
Angel Academe
Angel Academe is the UK’s leading angel network backing early-stage, high-growth businesses with at least one female founder. Since 2014, the network has backed 48+ businesses, helping them raise over £150 million from angels, VCs and family offices to continue to grow their businesses.
More Information
Angels@Essex
Angels@Essex is an invitation-only investment platform that links angel investors to entrepreneurs with innovative ideas, allowing new disruptive technologies to flourish.
More Information
Anglo American Decarbonisation Ventures
Anglo American’s Decarbonisation Ventures team invests in start-ups with the potential to achieve greater than 0.5Gt of decarbonisation per year of scale.
More Information
Anticus Partners
We are equity investors currently with two funds under management, The Finance Yorkshire Seedcorn Fund and The Finance Yorkshire Growth Fund.
More Information
Archangels
Archangels is a prominent business angel syndicate, which has been at the forefront of early stage investing in Scotland for over 30 years.
More Information
Ascension Ventures Limited
Ascension is an early-stage venture capital firm built and managed by exited operators and entrepreneurs to back the next generation of tech and impact founders.
More Information
Astanor
Astanor Ventures is a global B Corp certified impact venture capital investor that backs ambitious entrepreneurs with disruptive, scalable solutions that will create systemic change across the agrifood value chain, from soil to gut.
More Information
Baltic Ventures
Baltic Ventures is a tech accelerator on a mission to support game-changing founding teams who are building the solutions and businesses of tomorrow.
More Information
Barclays Sustainable Impact Capital
The Barclays Sustainable Impact Capital investment mandate to invest £500 million in the equity of fast-growing, fast-growing, technology start-ups by 2027, helping to accelerate our clients’ transition towards a low-carbon economy.
More Information
Beringea
Beringea is a transatlantic venture capital investor that seeks to create lasting success for rapidly scaling entrepreneurial companies.
More Information
Black Seed Ventures
Black Seed is a community led by Black founders, for Black founders.
More Information
Bloc Ventures
Bloc Ventures is an early-stage venture capital investment company, focused on deep tech companies in the UK and Europe.
More Information
Boundary Capital Partners
Boundary Capital Partners LLP is an impact, for-profit, B2B technology investor.
More Information
Cambridge Angels
Cambridge Angels is a leading UK business angel network providing smart capital from entrepreneurs to entrepreneurs.
More Information
Cambridge Enterprise
Cambridge Enterprise Seed Funds has managed investments made by the University of Cambridge Venture Fund into new technology companies since 1995.
More Information
Cancer Research Horizons
Cancer Research Horizons (CRH, trading name for Cancer Research Technology Limited) is a specialist drug discovery, development and commercialisation company wholly owned by Cancer Research UK (CRUK, the world’s leading cancer charity) that fast tracks scientific breakthroughs for patient benefit.